Robert E. Waltermire - 02 Aug 2021 Form 3 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Senior VP, Chief Pharma Dev.
Signature
/s/ Brian J. Lynch, As Attorney-in-fact for Reporting Person
Issuer symbol
MDGL
Transactions as of
02 Aug 2021
Net transactions value
$0
Form type
3
Filing time
04 Aug 2021, 21:36:58 UTC
Next filing
24 Feb 2022
SEC
View on sec.gov

Quoteable Key Fact

"Robert E. Waltermire filed Form 3 for MADRIGAL PHARMACEUTICALS, INC. (MDGL) on 04 Aug 2021."

Quick Takeaways

  • This page summarizes Robert E. Waltermire's Form 3 filing for MADRIGAL PHARMACEUTICALS, INC. (MDGL).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 04 Aug 2021, 21:36.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

No securities are beneficially owned.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .